Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Brooklyn › NPI 1356406136
Physician

New York City Health and Hospitals Corporation

New York City Health and Hospitals Corporation was paid $48.88M by Medicaid between Jan 2018 and Dec 2024, across 273 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 21% of everything it billed.

33Billing provider infoNEW YORK CITY HEALTH AND HOSPITALS CORPORATION
BROOKLYN, NY 11205
33aNPI1356406136assigned 12/22/2006
33bProvider typeInternal Medicine Physician
28Total paid$48.88M
24GClaims1,496,028
24DCodes billed273
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Internal Medicine Physician providers in New York

Rank by total paid#12 of 6,049
Median peer was paid$11K
This provider vs. median4,321×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official KARLIN, MARJI controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20183,564$128K
201997,452$3.09M
2020274,291$9.94M
2021357,378$11.59M
2022283,551$9.25M
2023283,373$8.80M
2024incomplete196,419$6.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 21% 134,463 98,567 $10.39M
36415 Collection of venous blood by venipuncture 7.2% 348,443 90,036 $3.50M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 6.1% 28,773 23,779 $2.98M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 6.0% 47,216 35,040 $2.95M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 4.1% 26,886 22,052 $2.02M
99442 3.2% 18,821 17,276 $1.55M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.9% 15,223 13,276 $1.43M
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 2.6% 10,886 10,679 $1.27M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 2.2% 10,972 10,077 $1.08M
99441 1.7% 12,315 11,552 $822K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.7% 25,355 22,905 $819K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.6% 41,311 40,712 $782K
261 more codes
90832 Psychotherapy session, about 30 minutes 1.5% 7,984 $757K
90460 Immunization administration through 18 years of age via any route, first or only component 1.5% 18,589 $722K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.4% 22,592 $706K
90834 Psychotherapy session, about 45 minutes 1.2% 4,725 $605K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 1.2% 4,774 $587K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 1.2% 5,829 $563K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.1% 12,401 $546K
86480 1.1% 8,677 $542K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1.1% 6,957 $515K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1.0% 26,126 $504K
99203 Doctor's office visit, new patient (routine) 1.0% 4,099 $499K
80061 Lipid panel <1% 39,189 $458K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 3,466 $450K
90461 <1% 7,847 $396K
90750 <1% 2,113 $355K
80053 Comprehensive metabolic panel <1% 29,671 $354K
99204 Doctor's office visit, new patient (more involved) <1% 2,121 $349K
90472 Immunization administration, each additional vaccine (list separately) <1% 13,354 $302K
86703 <1% 21,590 $301K
85027 <1% 53,564 $287K
99443 <1% 2,834 $279K
83036 Hemoglobin; glycosylated (A1C) <1% 33,604 $271K
99215 Doctor's office visit, returning patient (complex) <1% 1,546 $268K
H2010 Comprehensive medication services, per 15 minutes <1% 4,244 $268K
U0001 Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel <1% 6,405 $263K
84443 Thyroid stimulating hormone (TSH) <1% 19,051 $261K
D0999 Unspecified diagnostic procedure, by report <1% 1,500 $238K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 9,572 $229K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 7,747 $217K
99383 <1% 1,669 $210K
92551 <1% 11,055 $198K
90686 <1% 16,793 $196K
90651 <1% 3,914 $194K
99385 <1% 1,447 $192K
82962 <1% 12,875 $192K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,563 $187K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient <1% 1,965 $186K
99384 <1% 1,370 $184K
H0005 Alcohol and/or drug services; group counseling by a clinician <1% 2,469 $182K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 3,745 $181K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 6,635 $178K
90677 <1% 990 $173K
86769 <1% 5,116 $159K
3074F <1% 24,882 $152K
D9999 Unspecified adjunctive procedure, by report <1% 1,013 $145K
90746 <1% 2,345 $141K
90620 <1% 2,600 $140K
86780 <1% 10,339 $132K
99382 <1% 1,039 $127K
83655 <1% 9,286 $123K
96127 <1% 19,199 $118K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient <1% 960 $113K
86803 <1% 8,602 $107K
G0397 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes <1% 729 $107K
90715 <1% 4,288 $106K
92012 Ophthalmological services: medical examination and evaluation, intermediate, established patient <1% 1,207 $100K
99381 <1% 963 $100K
81001 <1% 18,530 $84K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 2,431 $81K
99051 <1% 3,612 $80K
80048 Basic metabolic panel (calcium, ionized) <1% 7,776 $78K
0012A <1% 2,160 $77K
T1013 Sign language or oral interpretive services, per 15 minutes <1% 4,521 $76K
99201 <1% 888 $73K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 731 $68K
87340 <1% 6,661 $66K
86706 <1% 6,332 $63K
0011A <1% 2,148 $62K
99386 <1% 423 $62K
80076 <1% 6,639 $58K
99397 <1% 877 $56K
90670 <1% 2,661 $51K
97802 <1% 2,022 $51K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 160 $51K
90732 <1% 455 $48K
83020 <1% 3,513 $47K
D0120 Dental checkup, returning patient <1% 2,358 $46K
86003 <1% 968 $45K
97803 <1% 1,273 $44K
86762 <1% 3,195 $44K
90837 Psychotherapy session, about an hour <1% 309 $43K
90697 <1% 303 $43K
82607 <1% 3,151 $43K
86704 <1% 3,918 $43K
84439 <1% 5,160 $42K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,174 $42K
0064A <1% 1,050 $42K
86765 <1% 3,148 $39K
92015 Determination of refractive state <1% 1,808 $36K
88142 <1% 1,551 $35K
82728 <1% 2,648 $34K
90716 <1% 1,322 $34K
90707 <1% 1,326 $33K
87800 <1% 878 $33K
84153 <1% 2,000 $32K
86787 <1% 3,047 $32K
90734 <1% 2,661 $30K
86735 <1% 2,783 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,612 $25K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 866 $24K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 732 $24K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,126 $23K
99401 <1% 545 $22K
83550 <1% 2,899 $21K
81025 <1% 3,150 $21K
90480 <1% 458 $21K
90633 <1% 2,647 $19K
G0470 Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit <1% 1,097 $19K
82274 <1% 1,663 $19K
11721 <1% 442 $19K
90656 <1% 1,544 $18K
83540 <1% 2,930 $17K
82043 <1% 3,148 $17K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 111 $16K
87536 <1% 162 $16K
82785 <1% 984 $15K
90791 Psychiatric diagnostic evaluation <1% 93 $15K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 32 $14K
G0467 Community health center visit, returning patient <1% 2,542 $13K
86593 <1% 3,082 $13K
D0140 Limited oral evaluation - problem focused <1% 600 $12K
71046 Radiologic examination, chest; 2 views <1% 420 $12K
84702 <1% 793 $11K
90710 <1% 1,162 $11K
77063 Screening digital breast tomosynthesis, bilateral <1% 207 $10K
86708 <1% 925 $10K
90744 <1% 1,296 $10K
91322 <1% 117 $10K
90674 <1% 534 $10K
87081 <1% 1,604 $10K
90698 <1% 1,638 $9K
99173 <1% 1,848 $9K
81003 <1% 4,010 $9K
76641 <1% 74 $8K
96161 <1% 1,135 $8K
86696 <1% 443 $8K
84154 <1% 425 $8K
90474 <1% 516 $8K
90714 <1% 342 $7K
86360 <1% 133 $7K
81002 <1% 1,598 $7K
0124A <1% 138 $7K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 792 $6K
82948 <1% 225 $6K
86695 <1% 439 $6K
86580 <1% 499 $6K
86359 <1% 134 $6K
87486 <1% 162 $5K
83001 <1% 267 $5K
D1110 Prophylaxis - adult <1% 381 $5K
84703 <1% 916 $5K
90696 <1% 939 $5K
90680 <1% 1,054 $5K
87581 <1% 162 $5K
G0511 Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month <1% 65 $4K
90473 <1% 226 $4K
92250 <1% 82 $4K
80320 <1% 629 $4K
90736 <1% 28 $4K
82951 <1% 375 $4K
90713 <1% 283 $4K
86140 <1% 812 $4K
99188 <1% 205 $3K
84460 <1% 600 $3K
0134A <1% 78 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 293 $3K
92083 <1% 44 $3K
82947 <1% 706 $3K
D0220 Intraoral - periapical first radiographic image <1% 612 $3K
84146 <1% 140 $3K
90792 Psychiatric diagnostic evaluation with medical services <1% 15 $3K
99205 Prolong outpt/office vis <1% 12 $3K
Q3014 Telehealth originating site facility fee <1% 79 $2K
0154A <1% 56 $2K
87522 Neg quan hep c or qual rna <1% 55 $2K
82465 <1% 555 $2K
84450 <1% 404 $2K
90672 <1% 326 $2K
92134 <1% 44 $2K
99422 <1% 26 $2K
88141 <1% 80 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 147 $2K
90694 <1% 40 $2K
83002 <1% 87 $2K
90653 <1% 50 $2K
76830 Ultrasound, transvaginal <1% 13 $2K
81015 <1% 592 $2K
0013A <1% 40 $2K
84403 <1% 61 $2K
T1023 Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter <1% 13 $1K
D0601 <1% 41 $1K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 587 $1K
87186 <1% 138 $1K
84480 <1% 90 $1K
86038 <1% 120 $1K
85651 <1% 310 $1K
82565 <1% 210 $1K
87338 <1% 79 $897.80
90723 <1% 253 $892.52
91319 <1% 75 $858.55
G0466 Community health center visit, new patient <1% 59 $820.35
82105 <1% 56 $814.57
84520 <1% 210 $809.88
92202 <1% 40 $802.91
91320 <1% 31 $795.13
84436 <1% 109 $704.14
90647 <1% 262 $696.64
90700 <1% 108 $686.96
84402 <1% 27 $649.48
86850 <1% 48 $632.12
83718 <1% 77 $606.29
80069 <1% 64 $601.42
90662 <1% 19 $594.58
85730 <1% 105 $586.95
85610 <1% 176 $570.29
85660 <1% 104 $528.88
90671 <1% 61 $453.18
72100 <1% 15 $452.70
84478 <1% 64 $438.05
84481 <1% 28 $416.97
85007 <1% 128 $415.58
86592 <1% 88 $411.60
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion <1% 22 $407.66
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only <1% 69 $391.11
D0330 Panoramic radiographic image <1% 53 $372.24
86901 <1% 48 $357.24
84550 <1% 72 $312.19
G0447 Face-to-face behavioral counseling for obesity, 15 minutes <1% 1,053 $311.66
G0008 Administration of influenza virus vaccine <1% 43 $306.90
D0274 Bitewings - four radiographic images <1% 28 $294.61
85045 <1% 67 $276.23
87350 <1% 24 $271.00
90660 <1% 32 $247.82
86900 <1% 48 $242.99
82746 <1% 14 $213.69
90661 <1% 39 $189.41
90681 <1% 12 $164.49
86707 <1% 12 $132.14
D1320 <1% 54 $130.55
90685 <1% 127 $125.05
D0150 Comprehensive oral evaluation - new or established patient <1% 13 $120.12
83516 <1% 12 $119.78
82248 <1% 25 $108.40
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 272 $97.09
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 125 $95.24
90648 <1% 22 $53.57
94760 <1% 13 $45.51
D0230 Intraoral - periapical each additional radiographic image <1% 12 $18.00
3078F <1% 19,473 $6.25
90611 <1% 50 $0.03
3075F <1% 5,490 $0.01
3079F <1% 6,652 $0.01
3080F 0% 1,145 $0.00
1220F 0% 262 $0.00
3008F 0% 677 $0.00
3044F 0% 14 $0.00
3077F 0% 2,925 $0.00
1160F 0% 1,721 $0.00
99499 0% 775 $0.00
1159F 0% 2,609 $0.00
99223 Prolong inpt eval add15 m 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKARLIN, MARJI (CHIEF REVENUE OFFICER)
Same official

Other billing entities under KARLIN, MARJI

Full network →
ProviderLocationPaid
New York City Health and Hospitals CorporationBronx, NY$217.68M
New York City Health and Hospitals CorporationBrooklyn, NY$178.84M
New York City Health and Hospitals CorporationNew York, NY$176.33M
New York City Health and Hospitals CorporationBronx, NY$160.32M
New York City Health and Hospitals CorporationElmhurst, NY$146.57M
New York City Health and Hospitals CorporationJamaica, NY$125.54M
New York City Health and Hospitals CorporationBrooklyn, NY$119.27M
New York City Health and Hospitals CorporationNew York, NY$108.18M
New York City Health and Hospitals CorporationBrooklyn, NY$107.34M
New York City Health and Hospitals CorporationNew York, NY$100.78M
New York City Health and Hospitals CorporationNew York, NY$57.46M
New York City Health and Hospitals CorporationBronx, NY$34.62M
New York City Health and Hospitals CorporationBrooklyn, NY$30.93M
New York City Health and Hospitals CorporationBronx, NY$19.59M
New York City Health and Hospitals CorporationBronx, NY$16.91M
New York City Health and Hospitals CorporationBrooklyn, NY$5.55M
New York City Health & Hospitals CorporationBrooklyn, NY$896K
New York City Health and Hospitals CorporationBrooklyn, NY$335K
New York City Health and Hospitals CorporationNew York, NY$410.07

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.